ZEB1 and acute myeloid leukemia: As evidenced in mouse, the levels of ZEB1 are in general statistically lower than ZEB2 in primary AML cells, with the translocation driver mutation likely affecting the expression of these transcription factors (S11A Fig, left and right, respectively: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).